Abstract:Objective To detect the expression of peripheral blood free prostate specific antigen (fSPA),total prostate specific antigen (tSPA),prostate specific antigen density (PSAD) and prostate cancer gene 3 (PCA3) in prostate disease,and the significance of combined detection of fSPA,tSPA and PCA3.Methods 67 patients with prostate cancer,75 patients with prostatic hyperplasia and 70 healthy male were selected as the research objects from Dec.2014 to Jul.2016.The serum level of fSPA and tSPA was detected by chemiluminescence immune staining method.The prostate volume was tested by ultrasonic sound and PSAD value was calculated.The total RNA was extracted by Trizol,and the serum PCA3 mRNA expression was detected by RT-PCR.The specificity and sensitivity of combined detection of fSPA,tSPA and PCA3 were analyzed.Results The serum levels of fSPA,tSPA,PSAD and PCA3 in prostate cancer were significantly higher than those in patients with prostatic hyperplasia and healthy male,and they were higher in patients with hyperplasia of prostate than in healthy male,and the differences had statistical significance (P＜0.01).The serum levels of fSPA,tSPA,PSAD and PCA3 were higher in patients with Gleason score ≥7 points and in T3-T4 stage than in patients with Gleason score ＜7 and in T1-T2 stage,and the difference had statistical significance (P＜0.01).The serum levels of fSPA,tSPA,PSAD and PCA3 were positively correlated with Gleason score and TMN pathological stage,and the difference had statistical significance (P＜0.01).The AUC value of fSPA,tSPA,PSAD and PCA3 in diagnosis of prostate cancer was 0.53,0.57,0.63 and 0.75,and the AUC value of combined detection was 0.92.The combined detection efficiency was higher than the single index.The specificity of fSPA,tSPA,PSAD and PCA3 was 67.16％,68.66％,73.13％ and 85.07％,and the sensitivity was 71.64％,70.15％,74.63％ and 82.09％ respectively.The specificity of combined detection was 97.01％,the sensitivity was 92.54％,and the difference had statistical significance (P＜0.01).Conclusion The serum level of fSPA,tSPA,PSAD and PCA3 is increased in prostate disease,and is negatively correlated with Gleason score and TMN pathological stage.The combined detection of fSPA,tSPA,PSAD and PCA3 can improve the sensitivity and specificity of prostate disease diagnosis,and is of high clinical value.

[Study on the correlation between glycolipids and prostate volume in patients with benign prostatic hyperplasia]

Applied Research of Prostate Specific Antigen Combined with Prostate Cancer Gene 3 in Diagnosis of Prostate Disease

The effect of patients′ age and prostatic volume on serum prostate specific antigen (PSA) level

Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia

[Correlation of Benign Prostatic Hyperplasia with Hyperlipemia].

[Correlation Analysis of Prostate Volume with Body Mass Index, Blood Pressure, Blood Lipid and Glucose in 30-50 Year-Old Men].

Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients.

Study on the relationship between age,prostate volume and prostate specific antigen of patients with benign prostatic hyperplasia

Correlation of Diabetes Control with Benign Prostatic Hyperplasia in T2DM Patients

The Association of Prostatic Lipids with Progression, Racial Disparity and Discovery of Biomarkers in Prostate Cancer

The Influence of Prostate Volume on Cancer Detection in the Chinese Population.

A Retrospective Study: Correlation of Histologic Inflammation in Biopsy Specimens of Chinese Men Undergoing Surgery for Benign Prostatic Hyperplasia with Serum Prostate-Specific Antigen.

Comparing Clinical Parameters of Abnormal and Normal Fasting Blood Glucose in Benign Prostatic Hyperplasia Patients.

Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial

Prostate-specific antigen, androgen, progesterone and oestrogen receptors in Benign prostatic hyperplasia: human tissues and animal model study

The correlation between lipid abnormality and benign prostatic hyperplasia in men receiving physical examination

Circulating Levels of Blood Biomarkers and Risk of Benign Prostatic Hyperplasia: Results from Two Large Cohorts in Europe and East Asia

The Effect of Prostatitis With Benign Prostatic Hyperplasia on Serum Prostate Specific Antigen Level

Predictive Factors for Tissue Inflammation in Patients with Benign Prostatic Hyperplasia: A Clinical Prediction Study

Correlation between Hyperuricemia and Benign Prostatic Hyperplasia

[Significance of Prostate Central Gland/total Gland Volume Ratio Combined with PSA in the Diagnosis of Prostate Cancer Patients].